Bivalirudin Bivalirudin Bivalirudin (Angiomax or Angiox, manufactured by The Medicines Company) is a direct thrombin inhibitor (DTI). Chemically, it is a synthetic congener of the naturally occurring drug hirudin (found in the saliva of the medicinal leech "Hirudo medicinalis"). Bivalirudin is a DTI that overcomes many limitations seen with indirect thrombin inhibitors, such as heparin. Bivalirudin is a short, synthetic peptide. It is a potent and highly specific inhibitor of thrombin. It inhibits both circulating and clot-bound thrombin, while also inhibiting thrombin-mediated platelet activation and aggregation. Bivalirudin has a quick onset of action and a short half-life. It does not bind
Ectopic salivary gland tissue the salivary glands, including cancer, may also occur within an accessory salivary gland tissue. "Salivary gland heterotopia" is where salivary gland acini cells are present in an abnormal location without any duct system. The most common location is the cervical lymph nodes. Other reported sites of heterotopic salivary gland tissue are the middle ear, parathyroid glands, thyroid gland, pituitary gland, cerebellar pontine angle, soft tissue medial to sternocleidomastoid, stomach, rectum and vulva. Salivary gland neoplasm occurrence within heterotopic salivary gland tissue is rare. Ectopic salivary gland tissue Ectopic salivary gland tissue which is located in sites other than the normal